AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 281: L98-L107, 2001;
1040-0605/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vivekananda, J.
Right arrow Articles by King, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vivekananda, J.
Right arrow Articles by King, R. J.
Vol. 281, Issue 1, L98-L107, July 2001

Sphingomyelin metabolites inhibit sphingomyelin synthase and CTP:phosphocholine cytidylyltransferase

Jeevalatha Vivekananda, Dolphin Smith, and Richard J. King

Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900

Tissue injury in inflammation involves the release of several cytokines that activate sphingomyelinases and generate ceramide. In the lung, the impaired metabolism of surfactant phosphatidylcholine (PC) accompanies this acute and chronic injury. These effects are long-lived and extend beyond the time frame over which tumor necrosis factor (TNF)-alpha and interleukin-1beta are elevated. In this paper, we demonstrate that in H441 lung cells these two processes, cytokine-induced metabolism of sphingomyelin and the inhibition of PC metabolism, are directly interrelated. First, metabolites of sphingomyelin hydrolysis themselves inhibit key enzymes necessary for restoring homeostasis between sphingomyelin and its metabolites. Ceramide stimulates sphingomyelinases as effectively as TNF-alpha , thereby amplifying the sphingomyelinase activation, and TNF-alpha , ceramide, and sphingosine all inhibit PC:ceramide phosphocholine transferase (sphingomyelin synthase), the enzyme that restores homeostasis between sphingomyelin and ceramide pools. Second, ceramide inhibits PC synthesis, probably because of its effects on CTP:phosphocholine cytidylyltransferase, the rate-limiting enzymatic step in de novo PC synthesis. The data presented here suggest that TNF-alpha may be an inhibitor of phospholipid metabolism in inflammatory tissue injury. These actions may be amplified because of the ability of metabolites of sphingomyelin to inhibit the pathways that should restore the normal ceramide-sphingomyelin homeostasis.

sphingosine; tumor necrosis factor-alpha ; pulmonary surfactant; cytidine 5'-triphosphate


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Uhlig and E. Gulbins
Sphingolipids in the Lungs
Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1100 - 1114.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. von Bismarck, C.-F. Garcia Wistadt, K. Klemm, S. Winoto-Morbach, U. Uhlig, S. Schutze, D. Adam, B. Lachmann, S. Uhlig, and M. F. Krause
Improved Pulmonary Function by Acid Sphingomyelinase Inhibition in a Newborn Piglet Lavage Model
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1233 - 1241.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. Sparkman, H. Chandru, and V. Boggaram
Ceramide decreases surfactant protein B gene expression via downregulation of TTF-1 DNA binding activity
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L351 - L358.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. Ridsdale, M. Roth-Kleiner, F. D'Ovidio, S. Unger, M. Yi, S. Keshavjee, A. K. Tanswell, and M. Post
Surfactant Palmitoylmyristoylphosphatidylcholine Is a Marker for Alveolar Size during Disease
Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 225 - 232.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
G. Liu, M. H. Ghahremani, B. Banihashemi, and P. R. Albert
Diacylglycerol and ceramide formation induced by dopamine D2S receptors via Gbeta gamma -subunits in Balb/c-3T3 cells
Am J Physiol Cell Physiol, March 1, 2003; 284(3): C640 - C648.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. J. Ryan, D. M. McCoy, S. E. McGowan, R. G. Salome, and R. K. Mallampalli
Alveolar sphingolipids generated in response to TNF-alpha modifies surfactant biophysical activity
J Appl Physiol, January 1, 2003; 94(1): 253 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. Ramos, M. E. Mouedden, E. Claro, and S. Jackowski
Inhibition of CTP:Phosphocholine Cytidylyltransferase by C2-Ceramide and Its Relationship to Apoptosis
Mol. Pharmacol., November 1, 2002; 62(5): 1068 - 1075.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
O. L. Miakotina and J. M. Snyder
TNF-alpha inhibits SP-A gene expression in lung epithelial cells via p38 MAPK
Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L418 - L427.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Awasthi, J. Vivekananda, V. Awasthi, D. Smith, and R. J. King
CTP:phosphocholine cytidylyltransferase inhibition by ceramide via PKC-{alpha}, p38 MAPK, cPLA2, and 5-lipoxygenase
Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L108 - L118.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online